SCHEMBL6555142

SCHEMBL6555142

CCOc1cc(CO)cc(OCOC)c1I

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.35
CREBBP Q92793 1/20 0.34
CALM1 P0DP23 3/20 0.33
TSHR P16473 3/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
CYP3A4 P08684 1/20 0.32
EGFR P00533 2/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
BPTF Q12830 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6556765 0.89 HTT (0.40) HTTCREBBPCALM1TSHRMAPT
SCHEMBL2952226 0.78 MAPT (0.41) HTTCREBBPTSHRMAPTSMN1; SMN2
SCHEMBL16055850 0.78 HTT (0.36) HTTCREBBPTSHRMAPTLMNA
SCHEMBL23202761 0.77 HSD17B10 (0.41) TSHRMAPTALOX15HSD17B10HTR2A
SCHEMBL6872463 0.76 CREBBP (0.44) CREBBPTSHRLMNAEGFRMEN1
SCHEMBL6555157 0.76 MRGPRX4 (0.49) MAPTSMN1; SMN2LMNAMEN1KMT2A
SCHEMBL1748593 0.75 ALDH1A1 (0.47) TSHRMAPTLMNAMEN1KMT2A
SCHEMBL6557178 0.75 TP53 (0.38) HTTTSHRMAPTALOX15HSD17B10
SCHEMBL26874199 0.75 HSD17B10 (0.43) HTTTSHRMAPTALOX15HSD17B10
SCHEMBL5058089 0.75 NPC1 (0.38) HTTTSHRCYP3A4EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230224-B1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2004-12-29 EP disclosed
US-6821980-B1 Substituted 5-benzyl-2,4-diaminopyrimidines BASILEA PHARMACEUTICA AG (CH) 2004-11-23 US disclosed
EP-1230224-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-14 EP disclosed
WO-2001032633-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2001-05-10 WO disclosed